Literature DB >> 8234346

D-chiro-inositol metabolism in diabetes mellitus.

R E Ostlund1, J B McGill, I Herskowitz, D M Kipnis, J V Santiago, W R Sherman.   

Abstract

D-chiro-inositol is a rare inositol isomer present in inositol phosphoglycans which are proposed mediators of insulin action. To study D-chiro-inositol metabolism in diabetes mellitus, a sensitive and specific assay was developed using negative-ion chemical ionization gas chromatography/mass spectrometry. Median urinary D-chiro-inositol excretion, which was 2.1 mumol/day in nondiabetics, was substantially increased to 12 mumol/day in non-insulin-dependent diabetes (P < 0.0001) and to 74 mumol/day in insulin-dependent diabetes (P < 0.0001). Urinary D-chiro-inositol was strongly correlated with fasting plasma glucose (r = 0.568, P < 0.0001), glycated hemoglobin (r = 0.529, P < 0.0001), and urinary glucose (r = 0.368, P = 0.01). The renal clearance of D-chiro-inositol was selectively elevated in both non-insulin-dependent and insulin-dependent diabetes when compared with the clearances of L-chiro-inositol or myo-inositol and exceeded the glomerular filtration rate in 71% of the diabetics but in none of the nondiabetics. In poorly controlled diabetic patients insulin treatment reduced urinary D-chiro-inositol losses by 63% and increased plasma levels by 8.8-fold. The metabolism of D-chiro-inositol is abnormal in diabetes and appears to be influenced by short- and long-term metabolic control.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234346      PMCID: PMC47698          DOI: 10.1073/pnas.90.21.9988

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Partial structure of an insulin-sensitive glycophospholipid.

Authors:  J M Mato; K L Kelly; A Abler; L Jarett; B E Corkey; J A Cashel; D Zopf
Journal:  Biochem Biophys Res Commun       Date:  1987-07-31       Impact factor: 3.575

2.  Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators.

Authors:  G Romero; L Luttrell; A Rogol; K Zeller; E Hewlett; J Larner
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

3.  Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase.

Authors:  A R Saltiel; J A Fox; P Sherline; P Cuatrecasas
Journal:  Science       Date:  1986-08-29       Impact factor: 47.728

Review 4.  Second messengers of insulin action.

Authors:  A R Saltiel
Journal:  Diabetes Care       Date:  1990-03       Impact factor: 19.112

5.  Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment.

Authors:  R S Clements; R Reynertson
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

6.  Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells.

Authors:  J M Mato; K L Kelly; A Abler; L Jarett
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

7.  Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol.

Authors:  J Larner; L C Huang; C F Schwartz; A S Oswald; T Y Shen; M Kinter; G Z Tang; K Zeller
Journal:  Biochem Biophys Res Commun       Date:  1988-03-30       Impact factor: 3.575

8.  Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

Authors:  A S Kennington; C R Hill; J Craig; C Bogardus; I Raz; H K Ortmeyer; B C Hansen; G Romero; J Larner
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

  8 in total
  31 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

2.  Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.

Authors:  N R F Nascimento; L M A Lessa; M R Kerntopf; C M Sousa; R S Alves; M G R Queiroz; J Price; D B Heimark; J Larner; X Du; M Brownlee; A Gow; C Davis; M C Fonteles
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

3.  The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.

Authors:  Hao-Han Chang; Bernard Choong; Anthony R J Phillips; Kerry M Loomes
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-24

4.  Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.

Authors:  Kai I Cheang; Jean-Patrice Baillargeon; Paulina A Essah; Richard E Ostlund; Teimuraz Apridonize; Leila Islam; John E Nestler
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

5.  myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol.

Authors:  R J Arner; K S Prabhu; J T Thompson; G R Hildenbrandt; A D Liken; C C Reddy
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism.

Authors:  Peter M Brown; Tom T Caradoc-Davies; James M J Dickson; Garth J S Cooper; Kerry M Loomes; Edward N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-29       Impact factor: 11.205

Review 7.  D-chiro-inositol glycans in insulin signaling and insulin resistance.

Authors:  Joseph Larner; David L Brautigan; Michael O Thorner
Journal:  Mol Med       Date:  2010-08-27       Impact factor: 6.354

8.  Differential gene expression in pancreatic tissues of streptozocin-induced diabetic rats and genetically-diabetic mice in response to hypoglycemic dipeptide cyclo (His-Pro) treatment.

Authors:  Song Ah Choi; Hyung Joo Suh; Jong Won Yun; Jang Won Choi
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

9.  Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes.

Authors:  Pia Marlene Nissen; Caroline Nebel; Niels Oksbjerg; Hanne Christine Bertram
Journal:  J Biomed Biotechnol       Date:  2010-08-10

Review 10.  Phytotherapy in diabetes: Review on potential mechanistic perspectives.

Authors:  Hanan S El-Abhar; Mona F Schaalan
Journal:  World J Diabetes       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.